Live
- Govt to launch 3 apps to protect consumers in digital marketplace
- NDA to fight Bihar polls with Nitish as CM face
- Allu Arjun refused to leave even after he was told of woman’s death
- Bareilly court summons Rahul Gandhi
- ‘Systematic conspiracy’ to undermine EC’s integrity: Kharge
- Popcorn tax slabs anger Congress
- India, Kuwait elevate ties to strategic level
- Nizamabad MP Dharmapuri Arvind and Jagtial MLA Dr. Sanjay Kumar Meet CM Revanth Reddy
- Hyderabad CP CV Anand Issues Stern Warning to Bouncers
- MP Laxman Criticizes Police Conduct, Calls for Support for Victims' Families
Sun Pharma gets FDA observation for Baska plant
Highlights
New Delhi: Drug major Sun Pharma on Monday said it has received one observation from the US health regulator for its Baska manufacturing facility in...
New Delhi: Drug major Sun Pharma on Monday said it has received one observation from the US health regulator for its Baska manufacturing facility in Gujarat.
In a regulatory filing, the Mumbai-based company said the US Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) of Baska facility from January 28 to February 5, 2019.
"At the conclusion of the inspection, the USFDA issued a Form 483, with one observation for which the company has submitted the response," it added.
Next Story
ADVERTISEMENT
